JP2017083341A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017083341A5 JP2017083341A5 JP2015212939A JP2015212939A JP2017083341A5 JP 2017083341 A5 JP2017083341 A5 JP 2017083341A5 JP 2015212939 A JP2015212939 A JP 2015212939A JP 2015212939 A JP2015212939 A JP 2015212939A JP 2017083341 A5 JP2017083341 A5 JP 2017083341A5
- Authority
- JP
- Japan
- Prior art keywords
- vitamin
- determination value
- deficiency
- specific item
- estimation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000010011 Vitamin A Deficiency Diseases 0.000 claims 39
- 238000012360 testing method Methods 0.000 claims 39
- 238000005259 measurement Methods 0.000 claims 21
- 238000007689 inspection Methods 0.000 claims 13
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 12
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 claims 9
- 229910001415 sodium ion Inorganic materials 0.000 claims 9
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims 8
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims 8
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims 8
- 230000007935 neutral effect Effects 0.000 claims 8
- 235000019155 vitamin A Nutrition 0.000 claims 8
- 239000011719 vitamin A Substances 0.000 claims 8
- 229940045997 vitamin a Drugs 0.000 claims 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 6
- 235000012000 cholesterol Nutrition 0.000 claims 6
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 claims 5
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 claims 5
- 229940116269 uric acid Drugs 0.000 claims 5
- 230000002950 deficient Effects 0.000 claims 4
- 238000004820 blood count Methods 0.000 claims 3
- 210000003743 erythrocyte Anatomy 0.000 claims 3
- 210000002966 serum Anatomy 0.000 claims 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015212939A JP6566422B2 (ja) | 2015-10-29 | 2015-10-29 | ビタミンａ欠乏推定装置、プログラム及び記録媒体 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015212939A JP6566422B2 (ja) | 2015-10-29 | 2015-10-29 | ビタミンａ欠乏推定装置、プログラム及び記録媒体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017083341A JP2017083341A (ja) | 2017-05-18 |
| JP2017083341A5 true JP2017083341A5 (enExample) | 2017-07-27 |
| JP6566422B2 JP6566422B2 (ja) | 2019-08-28 |
Family
ID=58710840
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015212939A Active JP6566422B2 (ja) | 2015-10-29 | 2015-10-29 | ビタミンａ欠乏推定装置、プログラム及び記録媒体 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6566422B2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6649914B2 (ja) | 2017-04-20 | 2020-02-19 | 株式会社Ｓｕｂａｒｕ | 画像表示装置 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5429586B2 (ja) * | 2007-03-30 | 2014-02-26 | 株式会社タニタ | 血糖状態推定方法及び装置 |
| JP6251552B2 (ja) * | 2013-11-22 | 2017-12-20 | 株式会社Ｎｔｔドコモ | 糖尿病指標値推定システム及び糖尿病指標値推定方法 |
| JP2015180865A (ja) * | 2014-03-06 | 2015-10-15 | 国立研究開発法人産業技術総合研究所 | ＭａｔｓｕｄａＩｎｄｅｘの予測方法及び装置、並びにインスリン抵抗性及び糖代謝異常の検出方法 |
-
2015
- 2015-10-29 JP JP2015212939A patent/JP6566422B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Scheitz et al. | Prognostic relevance of cardiac troponin T levels and their dynamic changes measured with a high-sensitivity assay in acute ischaemic stroke: analyses from the TRELAS cohort | |
| Matos et al. | Handgrip strength at baseline and mortality risk in a cohort of women and men on hemodialysis: a 4-year study | |
| RU2016141788A (ru) | Система и способ обнаружения и предотвращения вождения при неспособности осуществлять вождение | |
| JP2016177151A5 (enExample) | ||
| BR112019009614A8 (pt) | Sistema para medir integralmente parâmetros clínicos da função visual | |
| WO2016046640A3 (en) | Methods for predicting drug responsiveness | |
| JP2014140490A5 (enExample) | ||
| Stone Jr et al. | End-tidal CO2 on admission is associated with hemorrhagic shock and predicts the need for massive transfusion as defined by the critical administration threshold: a pilot study | |
| JP2017503264A5 (enExample) | ||
| JP2015152938A5 (enExample) | ||
| WO2014140974A3 (en) | System and method for determining risk of diabetes based on biochemical marker analysis | |
| JP2017083340A5 (enExample) | ||
| FI3777664T3 (fi) | Menetelmiä viiveen kompensoimiseksi analyyttimittauksia varten sekä niihin liittyviä laitteita | |
| Sardana et al. | Clinical and echocardiographic correlates of left atrial function index: the Framingham Offspring Study | |
| Ramaswamy et al. | Relationship of ambulatory blood pressure and body mass index to left ventricular mass index in pediatric patients with casual hypertension | |
| Patel et al. | Waist circumference and body mass index in children with chronic kidney disease and metabolic, cardiovascular, and renal outcomes | |
| US20160076930A1 (en) | Balance ability measurement apparatus, balance ability measurement method and non-transitory computer readable recording medium for recording balance ability measurement program | |
| JP2017522951A5 (enExample) | ||
| JP2017083341A5 (enExample) | ||
| WO2015197915A3 (en) | Biochemical markers for use in determining risk of diabetes | |
| JP2019077220A5 (enExample) | ||
| JP2009061246A5 (enExample) | ||
| JP2015225032A5 (enExample) | ||
| JP2019115585A5 (enExample) | ||
| Açıkgöz et al. | Comparison of MDRD formula with creatinine clearance in estimation of glomerular filtration rate |